Short sellers have sharply increased their positions against U.S. life insurance companies over the past year, with the aggregate value of those bearish bets rising to more than $5 billion, according to an analysis of ORTEX data. Market participants and analysts attribute at least part of this shift to anxiety over insurers' exposure to the private credit market - a less regulated segment of lending dominated by non-bank entities such as private equity funds and asset managers.
Private credit has drawn scrutiny in recent months after investors discovered that portfolio managers held debt issued by bankrupt auto companies and paper tied to a U.K. mortgage provider accused of fraud. Those developments have fed concern about the opacity and risk profile of loans originated outside the traditional banking system.
Mediolanum International Funds' head of fixed income, Daniel Loughney, summarized the unease plainly: "Concerns are not about a single blow‑up, but about potential structural vulnerabilities with the (private credit) asset class having much less regulation and oversight than the traditional banking system," he said. "Institutional exposure to the asset class has grown significantly over the past decade. Overall we see a problem brewing that will affect the life assurance markets, annuity markets and the asset management industry," Loughney added.
Ratings agency and insurance specialist AM Best reports that private credit holdings among U.S. life and annuity insurers have more than doubled over the last 10 years, a period that coincided with historically low official interest rates. The International Monetary Fund, citing Moody's data, has said U.S. life insurers have roughly a 35% portion of their balance sheet tied up in private lending. Private loans can offer higher yields and steady, long-duration cash flows that suit insurers' long-term payout obligations, which helps explain why allocations to the asset class have expanded.
Hedge funds and other short sellers appear to be capitalizing on these vulnerabilities. Traders added almost $3 billion to the value of short bets on 10 leading U.S. life insurance companies over the past year, bringing the total to around $5.3 billion, based on calculations using ORTEX data. That activity coincided with a more than 130% increase in the proportion of those companies' shares that traders borrowed in order to establish short positions.
Investor caution has also manifested in flows away from retail funds that package private loans to middle-market companies and make them available on public exchanges. Questions have emerged about the value of the underlying loans backing those funds, with many such loans having been made to companies in areas like AI infrastructure - sectors that have been hit by volatile tech market conditions.
Market performance has reflected some of these pressures. The S&P 500 U.S. insurance index, which includes life insurers, has slipped almost 5% so far this year, while the broader S&P 500 has climbed about 4.7% over the same period. Barclays analysts estimate that the collective earnings per share of 15 U.S. life insurance companies will decline by almost 7% over the course of this year, arguing that market pricing appears to already assume a "fairly severe" outcome - either a recessionary backdrop or notable losses within private credit portfolios. Those analysts added that the concerns may be overstated.
Short positions against insurance companies are not limited to the U.S. When examining global insurance firms, the value of short bets rose by more than 60% in the 12 months to April 15, reaching over $31 billion, according to calculations that used S&P Global and LSEG data.
At the individual company level, ORTEX data show sharp increases in short interest. Short positions in Principal Financial Group climbed by more than 80% in the past year, peaking at over 4% in March. Brighthouse Financial saw short interest reach a record high of over 13% of available stock on March 9. Both companies declined to comment on market activity. Short interest in Prudential grew to 3.27% from 1.96%; Prudential said that "while it does not comment on market activity, it remains focused on disciplined risk management...and long-term value creation."
Some market participants emphasize structural balance-sheet constraints among insurers, particularly those owned by private equity. "Life insurers owned by PE (private equity) firms are very long private assets and have very limited capital surplus available," said Alberto Gallo, founder of hedge fund Andromeda Capital. Gallo's firm holds bets against insurers' bonds, reflecting a broader strategy that targets potential stress points in insurer balance sheets.
Barclays, in a separate note dated April 20, argued that for most insurers the central problem may be transparency rather than immediate, acute credit failures. That view echoes concerns raised by a former insurance examiner and industry adviser, Tom Gober, who has tracked insurer use of opaque structures. Gober estimates that insurers have executed roughly $1.54 trillion worth of transactions into captive insurance subsidiaries - entities that can obscure the location and nature of holdings. He said recent regulatory changes in the United States may not go far enough to remedy the lack of transparency, especially regarding offshore positions.
Gober offered a pointed assessment of market responses to that opacity: "Perhaps the only regulatory-like message left is for the investment industry to wear the regulator’s hat and short the parent companies," he said.
With holdings in private credit having grown substantially and questions mounting over valuation and disclosure, market participants will continue to watch insurers' reporting and portfolio composition closely. The interplay of crowded private credit allocations, shifting investor sentiment, and short-sale activity has created a dynamic that investors, rating agencies, and regulators are monitoring for signs of wider strain across life assurance, annuities, and associated asset management businesses.
Summary
Short positions against U.S. life insurers have more than doubled to over $5 billion amid concern about exposure to private credit. Analysts cite growing institutional allocations to less-regulated private lending, rising short activity across both U.S. and global insurers, and calls for greater transparency around opaque structures such as captive insurance subsidiaries.
Key points
- Short interest on 10 major U.S. life insurers rose by nearly $3 billion in the past year, totaling about $5.3 billion and representing a greater than 130% rise in shares borrowed for shorts.
- Private credit allocations for life and annuity insurers have more than doubled over the past decade; U.S. life insurers have roughly 35% of their balance sheets tied to private lending, per IMF citing Moody's.
- Market and analyst signals include a nearly 5% drop in the U.S. insurance index year-to-date, Barclays' forecast for a near 7% EPS decline for 15 life insurers this year, and a 60% rise in global insurance short exposure to over $31 billion in the 12 months to April 15.
Risks and uncertainties
- Valuation risk in private credit portfolios - questions about the underlying loans, including those to AI infrastructure firms, may affect fund valuations and insurer balance sheets, impacting the asset management and insurance sectors.
- Transparency and disclosure concerns - opaque arrangements such as captive insurance subsidiaries (estimated at about $1.54 trillion in transactions) could mask true exposures, creating regulatory and investor uncertainty for insurers and their counterparties.
- Market sentiment and shorting pressure - elevated short interest and investor outflows from retail vehicles packaging private loans could amplify share-price volatility and strain capital positions, particularly for insurers with concentrated private credit holdings.